Press Release
January 31, 2014
Icon Genetics successfully completes Phase I clinical study with personalized vaccines for treatment of non-Hodgkin’s lymphoma
continue reading
Press Release
December 17, 2013
Icon Genetics and Bayer CropScience successfully completed the development of a plant host system with designer glycosylation needed for manufacturing biopharmaceuticals in green plants
continue reading
Press Release
November 01, 2012
Icon Genetics’ personalized vaccine clinical trials is featured in documentary series from Baylor Health Care System
continue reading
Press Release
September 20, 2012
Icon Genetics to Provide John Innes Centre Access to Golden Gate Cloning Platform
continue reading
Press Release
July 16, 2012
CSIR gets free access to Icon Genetics manufacturing technology
continue reading
Press Release
June 15, 2012
Frost & Sullivan’s to recognize Icon Genetics with the 2012 European Technology Innovation Award.
continue reading
Press Release
May 09, 2012
Icon Genetics and Bayer CropScience sign an agreement to develop production hosts with designer glycosylation
continue reading
Press Release
May 07, 2012
Kentucky Bioprocessing, Icon Genetics and Mapp Biopharmaceutical have entered into discussions to merge their businesses
continue reading
Press Release
March 15, 2012
Nomad Bioscience and Icon Genetics sign broad cross-license agreement
continue reading